{
  "chunk_id": "V_iii_7_None_10",
  "content": "/>\nV.iii.7.1.e\n.\nUrinary Tract Infection\nThe following terms are utilized in the criteria for evaluating urinary tract infection.\nSuppressive drug therapy\n, as identified in the criteria for the 0- and 10-percent disability evaluations, refers to the use of prolonged suppressive antibiotic therapy or medications for treatment of urinary tract infections.  The required duration of the therapy is identified in the rating criteria.\nContinuous intensive management\n, as identified in the criteria for the 30-percent disability evaluation, refers to the requirement for treatment beyond the use of antibiotic or other medications or hospitalizations as described in the 0- and 10-percent evaluation levels.  Examples of this level of care include but are not limited surgical management of the nephrostomy and/or stent, intravenous antibiotics, or treatment that is otherwise required for the maintenance of the nephrostomy tube or stent.",
  "title": "M21-1, Part V, Subpart iii, Chapter 7 - Genitourinary Disabilities",
  "citation": "Part V, Subpart iii, Chapter 7, Section None",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180593/M21-1-Part-V-Subpart-iii-Chapter-7-Genitourinary-Disabilities",
  "updated": "",
  "scraped_at": "2025-06-16T22:45:07.512056",
  "tags": [
    "m21-1"
  ]
}